[HTML][HTML] Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells
…, P Zhong, M Ghaedi, Z Hu, G Azabdaftari… - Nature …, 2012 - nature.com
Parkinson's disease (PD) is defined by the degeneration of nigral dopaminergic (DA)
neurons and can be caused by monogenic mutations of genes such as parkin. The lack of …
neurons and can be caused by monogenic mutations of genes such as parkin. The lack of …
Intratumoral and intertumoral genomic heterogeneity of multifocal localized prostate cancer impacts molecular classifications and genomic prognosticators
Background Next-generation sequencing is revealing genomic heterogeneity in localized
prostate cancer (CaP). Incomplete sampling of CaP multiclonality has limited the implications …
prostate cancer (CaP). Incomplete sampling of CaP multiclonality has limited the implications …
Serum glutamate levels correlate with Gleason score and glutamate blockade decreases proliferation, migration, and invasion and induces apoptosis in prostate …
S Koochekpour, S Majumdar, G Azabdaftari… - Clinical cancer …, 2012 - AACR
Purpose: During glutaminolysis, glutamine is catabolized to glutamate and incorporated into
citric acid cycle and lipogenesis. Serum glutamate levels were measured in patients with …
citric acid cycle and lipogenesis. Serum glutamate levels were measured in patients with …
YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage
…, C Ullio, S Pizzimenti, M Daga, G Azabdaftari… - Oncogene, 2016 - nature.com
Current standard of care for muscle-invasive urothelial cell carcinoma (UCC) is surgery
along with perioperative platinum-based chemotherapy. UCC is sensitive to cisplatin-based …
along with perioperative platinum-based chemotherapy. UCC is sensitive to cisplatin-based …
Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations
…, A Romanel, JR Osborne, JW Kim, G Azabdaftari… - Cancer discovery, 2017 - AACR
African-American men have the highest incidence of and mortality from prostate cancer.
Whether a biological basis exists for this disparity remains unclear. Exome sequencing (n = 102) …
Whether a biological basis exists for this disparity remains unclear. Exome sequencing (n = 102) …
[HTML][HTML] Akt activation by Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) in ovarian cancer cells
AM Gocher, G Azabdaftari, LM Euscher, S Dai… - Journal of Biological …, 2017 - ASBMB
Hyperactivation of Akt is associated with oncogenic changes in the growth, survival, and
chemoresistance of cancer cells. The PI3K/phosphoinositide-dependent kinase (PDK) 1 …
chemoresistance of cancer cells. The PI3K/phosphoinositide-dependent kinase (PDK) 1 …
Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer
…, NC Kaneider, K Lazarides, G Azabdaftari… - Molecular cancer …, 2008 - AACR
Gene chip and proteomic analyses of tumors and stromal tissue has led to the identification
of dozens of candidate tumor and host components potentially involved in tumor-stromal …
of dozens of candidate tumor and host components potentially involved in tumor-stromal …
[HTML][HTML] A regulatory feedback loop between Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) and the androgen receptor in prostate cancer …
LG Karacosta, BA Foster, G Azabdaftari… - Journal of Biological …, 2012 - ASBMB
The androgen receptor (AR) plays a critical role in prostate cancer (PCa) progression,
however, the molecular mechanisms by which the AR regulates cell proliferation in androgen-…
however, the molecular mechanisms by which the AR regulates cell proliferation in androgen-…
[HTML][HTML] Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer
…, N Krishnan, R Osiecki, G Azabdaftari… - Cell Death & …, 2019 - nature.com
Lysine-specific demethylase 6A (KDM6A) and members of the Switch/Sucrose Non-Fermentable
(SWI/SNF) family are known to counteract the activity of Enhancer of Zeste Homolog 2 (…
(SWI/SNF) family are known to counteract the activity of Enhancer of Zeste Homolog 2 (…
Predictors of complete pathologic response (pT0) to neoadjuvant chemotherapy in muscle-invasive bladder carcinoma
…, S Cyriac, R Pili, EG Levine, G Azabdaftari… - Clinical genitourinary …, 2016 - Elsevier
Background Randomized trials have supported the use of cisplatin-based neoadjuvant
chemotherapy (NAC) in muscle-invasive bladder carcinoma (MIBC) owing to the survival …
chemotherapy (NAC) in muscle-invasive bladder carcinoma (MIBC) owing to the survival …